Clinical Research Advantage, Inc./Simon Williamson Clinic, PC

Birmingham, Alabama 35211

0 studies enrolling now · 1 studies all time

What they study most

Episodic Migraine

Studies at this site

• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed